Questions Raised Over Accuracy of Xarelto Clinical Trials

A Michigan Xarelto lawyer notes that reports concerning the alleged inaccuracy of a blood-testing device used during Xarelto clinical trials have fueled concerns about the drug’s safety and that the trial results may have unfairly favored the blood-thinning drug. Patients who suffered uncontrollable bleeding and other serious side effects while taking Xarelto may be eligible to pursue compensation with the assistance of a Michigan Xarelto attorney.

For more information, contact Attorney Group for Michigan today. Our consultations are free, confidential and without any obligation on your part. We can help answer your questions, and if you choose to pursue a claim we can connect you with an affiliated Michigan Xarelto lawyer who can assist you throughout the legal process.

The time you have to pursue a claim is limited. Contact us for more information.Get Help Now.

Report: Xarelto Clinical Trial Results May Need Further Scrutiny

The clinical trials that supported the approval of the anticoagulant Xarelto have been called into question by reports that the blood-testing device used during these trials was allegedly faulty. As CBS News explains, the device may have incorrectly made Xarelto appear more safe and effective than the popular blood-thinner warfarin. Given reports linking Xarelto to serious or even fatal bleeding events, critics have worried that the drug was wrongly approved based on flawed trial data.

Johnson & Johnson and Bayer, the makers of Xarelto, commissioned a review of the clinical safety trials, which found that the faulty device didn’t affect the final results. However, attorneys representing patients who were allegedly injured by Xarelto have contended that this analysis didn’t take all available data into account. Furthermore, peer reviewers and editors at the New England Journal of Medicine, which published the review of the trials, weren’t advised that additional data was available. Critics have expressed concerns that this omission may have rendered the analysis inaccurate and that the trial results may require further scrutiny, the website reported.

How a Michigan Xarelto Lawyer Can Help

Drug manufacturers have a duty to ensure their products are accompanied by full and accurate instructions and warnings to guide prescribing doctors and other health care providers in making treatment decisions. If a drug maker fails to fulfill this duty, it could be held liable in lawsuits for injuries that may result.

Patients who are injured by Xarelto may be entitled to compensation for damages, including:

  • Medical expenses
  • The permanency of the injury
  • Pain, suffering, and mental anguish
  • Loss of income or ability to work

If a patient dies from complications after taking Xarelto, family members may be entitled to compensation for the wrongful death of their loved one, including:

  • Conscious pain and suffering of a loved one prior to death
  • Pain, suffering, and mental anguish from the loss of a loved one
  • Funeral expenses

Patients who have suffered severe side effects after taking Xarelto, as well as the families of those who have died as a result of complications with the drug, are encouraged to seek the advice of a Michigan Xarelto lawyer to learn more about their rights and remedies.

The Time You Have to Pursue a Claim is Limited. Contact Us Today.

For more information, contact Attorney Group for Michigan. You can fill out the form on this page, call us at the number listed at the top of the page, or email us at info@attorneygroup.com.

When you contact us, an attorney will follow up with you to speak with you about your case or answer questions that you might have. There is no cost or obligation to speak with us, and any information you provide will be kept confidential.

Please note that the law limits the time you have to pursue a claim for an injury. If you think you have a case, you should not delay taking action.

See our Frequently Asked Questions page for more information, and contact Attorney Group for Michigan today.

Comments